✦ LIBER ✦

A double-blind, randomized, placebo-controlled study assessing the efficacy and tolerability of desvenlafaxine 10 and 50 mg/day in adult outpatients with major depressive disorder

✍ Scribed by Michael R Liebowitz, Karen A Tourian, Eunhee Hwang, Linda Mele

Book ID: 120680804
Publisher: BioMed Central
Year: 2013
Tongue: English
Weight: 214 KB
Volume: 13
Category: Article
ISSN: 1471-244X
DOI: 10.1186/1471-244X-13-94

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy, safety, and tolerability of de

Efficacy, safety, and tolerability of desvenlafaxine 50 mg/day and 100 mg/day in outpatients with major depressive disorder*

✍ Liebowitz, Michael R.; Manley, Amy L.; Padmanabhan, Sudharshan K.; Ganguly, Rita 📂 Article 📅 2008 🏛 Informa plc 🌐 English ⚖ 168 KB

Efficacy and tolerability of mirtazapine

Efficacy and tolerability of mirtazapine vs citalopram: A double-blind, randomized study in patients with major depressive disorder

✍ H. Ågren; E. Leinonen; J. Skarstein; K. Behke; J.Th. Helsdingen 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 319 KB

Efficacy and tolerability of the novel t

Efficacy and tolerability of the novel triple reuptake inhibitor amitifadine in the treatment of patients with major depressive disorder: A randomized, double-blind, placebo-controlled trial

✍ Pierre Tran; Phil Skolnick; Pal Czobor; N.Y. Huang; Mark Bradshaw; Anthony McKin 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 297 KB

Paroxetine controlled-release formulatio

Paroxetine controlled-release formulation in the treatment of major depressive disorder: A randomized, double-blind, placebo-controlled study in Japan and Korea

✍ Teruhiko Higuchi; Jin Pyo Hong; Hee-Yeon Jung; Yoshinori Watanabe; Taro Kunitomi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 249 KB

Randomized, Double-Blind Study of the Ef

Randomized, Double-Blind Study of the Efficacy and Tolerability of Extended Release Quetiapine Fumarate (Quetiapine XR) Monotherapy in Elderly Patients with Major Depressive Disorder

✍ Katila, Heikki; Mezhebovsky, Irina; Mulroy, Amy; Berggren, Lovisa; Eriksson, Han 📂 Article 📅 2013 🏛 American Psychiatric Publishing Inc 🌐 English ⚖ 464 KB

Concerns about data reporting and interp

Concerns about data reporting and interpretation in “Efficacy and tolerability of the novel triple reuptake inhibitor amitifadine in the treatment of patients with major depressive disorder: A randomized, double-blind, placebo-controlled trial”

✍ David M. Marks; Jonathan S. Abramowitz; Glen I. Spielmans 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 84 KB